La nostra divisione coordina uno studio di fase II con fattori predittivi di risposta/resistenza a terapie anti-HER2 e loro correlazione con outcome clinico nelle pazienti arruolate nello studio clinico HERLAP.
OBJECTIVES Identification of molecular and genetic determinants of response/resistance to Trastuzumab and Lapatinib and their correlation to outcome, in patients enrolled in the phase II trial HERLAP.
1.220911026001s
Download our Word Games app for free!
Connect letters, discover words, and challenge your mind at every new level. Ready for the adventure?
OBJECTIVES Identification of molecular and genetic determinants of response/resistance to Trastuzumab and Lapatinib and their correlation to outcome, in patients enrolled in the phase II trial HERLAP. 